Cystic tumors of the pancreas are rare, accounting for 1%-5% of exocrine pancreatic tumors. Serous cystadenoma (SCA) was firstly described by Compagno and Oertel in 1978 as a benign glycogen-rich neoplasm [1]. In 1996 Perez-Ordonez et al. [2] reported the first case of a solid variant of SCA; since then, 23 cases of this extremely uncommon tumor variant were reported. Due to its rarity and unusual imaging appearance, a correct differential diagnosis is difficult and can lead to mistaken diagnosis and unnecessary treatment. According to Surgical CAse REport (SCARE) Guidelines [3], we present the second case of pancreatic solid SCA (SSCA) reported in Italy, the first surgically treated with a robotic approach worldwide.
Saragoni L., Pacilio C.A., Cavaliere D., Limarzi F., Isopi C., Ercolani G. (2022). Solid serous cystadenoma of the pancreas: A rare tumor with challenging differential diagnosis. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 21(3), 303-306 [10.1016/j.hbpd.2021.06.005].
Solid serous cystadenoma of the pancreas: A rare tumor with challenging differential diagnosis
Pacilio C. A.;Isopi C.;Ercolani G.
2022
Abstract
Cystic tumors of the pancreas are rare, accounting for 1%-5% of exocrine pancreatic tumors. Serous cystadenoma (SCA) was firstly described by Compagno and Oertel in 1978 as a benign glycogen-rich neoplasm [1]. In 1996 Perez-Ordonez et al. [2] reported the first case of a solid variant of SCA; since then, 23 cases of this extremely uncommon tumor variant were reported. Due to its rarity and unusual imaging appearance, a correct differential diagnosis is difficult and can lead to mistaken diagnosis and unnecessary treatment. According to Surgical CAse REport (SCARE) Guidelines [3], we present the second case of pancreatic solid SCA (SSCA) reported in Italy, the first surgically treated with a robotic approach worldwide.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.